Divco West Real Estate Services, LLC acquired 143,000 square feet, 5000 Shoreline Court, San Francisco from Johnson & Johnson for approximately 170 million.
January 12, 2022
Share
Divco West Real Estate Services, LLC acquired 143,000 square feet, 5000 Shoreline Court, San Francisco from Johnson & Johnson (NYSE:JNJ) for approximately 170 million on January 7, 2022. The Shoreline Court was sold for $1,140 a foot and will be vacated for lab conversion.
Divco West Real Estate Services, LLC completed the acquisition of 143,000 square feet, 5000 Shoreline Court, San Francisco from Johnson & Johnson (NYSE:JNJ) on January 7, 2022.
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows:
- pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.;
- medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals;
- consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc.
At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25).
Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
Divco West Real Estate Services, LLC acquired 143,000 square feet, 5000 Shoreline Court, San Francisco from Johnson & Johnson for approximately 170 million.
JOHNSON & JOHNSON 
